Cannabis use in HIV for pain and other medical symptoms

Journal of Pain and Symptom Management

Volumn 29, Issue 4, 2005, Pages 358-367

  Woolridge, Emily ^a   Barton, Simon ^a   Samuel, Jonathon ^a   Osorio, Jess ^a   Dougherty, Andrew ^a   Holdcroft, Anita ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Cannabis; HIV; Pain; Symptoms

Indexed keywords

CANNABIS;

ADULT; AGED; ANXIETY; APPETITE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MYALGIA; NAUSEA; NONHUMAN; OUTPATIENT; PAIN; PARESTHESIA; QUESTIONNAIRE; SYMPTOM; TREATMENT OUTCOME;

EID: 18044381739     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2004.07.011     Document Type: Article

References (40)

1. UNAIDS. Joint United Nations Programme on HIV and AIDS 2003. Available at www.unaids.org/en/resources/epidemiology.asp.
2. ONS, Office of National Statistics. HIV infections: By year of diagnosis and route of transmission 2002. Available at www.statistics.gov.uk/cci/nugget. asp?id=654.
3. A. Mocroft, S. Vella, and T.L. Benfield Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group Lancet 352 1998 1725 1730
4. M.A. Ware, C.R. Doyle, R. Woods, M.E. Lynch, and A.J. Clark Cannabis use for chronic non-cancer pain: Results of a prospective survey Pain 102 2003 211 216
5. M.A. Ware, S. Rueda, D. Kilby, and J. Singer Cannabis use among patients with HIV/AIDS: Patterns and prevalence of use J Cannabis Ther 3 2003 3 15
6. S. Sidney Marijuana Use in HIV positive and AIDS patients: Results of an anonymous mail survey E. Russo Cannabis therapeutics in HIV/AIDS 2001 The Haworth Press New York 35 41
7. D.A. Dansak Medical use of recreational drugs by AIDS patients J Addict Dis 16 1997 25 30
8. A. Carr, and D.A. Cooper Adverse effects of antiretroviral therapy Lancet 356 2000 423 430
9. S.C. Keswani, C.A. Pardo, and C.L. Cherry HIV-associated sensory neuropathies AIDS 16 2002 2105 2117
10. T.F. Plasse, R.W. Gorter, and S.H. Krasnow Recent clinical experience with dronabinol Pharmacol Biochem Behav 40 1991 695 700
11. F.M. Leweke, U. Schneider, and M. Radwan Different effects of nabilone and cannabidiol on binocular depth inversion in man Pharmacol Biochem Behav 66 2000 175 181
12. B. Sharrack, and R.A. Hughes The Guy's Neurological Disability Scale (GNDS): A new disability measure for multiple sclerosis Multiple Sclerosis 5 1999 223 233
13. Public Health Laboratory Report Feb 2003. Available at www.hpa.org.uk/infections/topics_az/hiv_and_sti/hiv/hiv.htm
14. C.H. Ashton, A. Holdcroft, and S. Mars Therapeutic uses of cannabis, British Medical Association 1997 Harwood Academic Publishers The Netherlands p. 77
15. Wesner B. The medical marijuana issue among PWAs: Reports of therapeutic use and attitudes towards legal reform. Working Paper No. 3, Working Paper series. Drug Research Unit, Social Science Research Institute, University of Hawaii. Available at http://www.drugpolicy.org/library/mmwesne.cfm. Accessed June 1996.
16. Prestage GS, Kippax S, Grulich A. Use of treatments and health enhancement behaviours among HIV positive men in a cohort of homosexually active men. XI International Conference on AIDS, Vancouver, BC, Canada, July 1996. Abstract thD 5181.
17. A. Ameri The effects of cannabinoids on the brain Prog Neurobiol 58 1999 15 48
18. C. Bell, G.V. Matthews, and M.R. Nelson Non-nucleoside reverse transcriptase inhibitors - an overview Int J STD AIDS 14 2003 71 77
19. S.E. Sallan, N.E. Zinberg, and E. Frei 3rd Anti-emetic effects of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy N Engl J Med 293 1975 795 797
20. A.E. Chang, D.J. Shiling, and R.C. Stillman Delta-9-tetrahydrocannabinol as an anti-emetic in cancer patients receiving high dose methotrexate Ann Intern Med 91 1979 819 824
21. D.S. Poster, J.S. Penta, S. Bruno, and J.S. Macdonald Delta-9-tetrahydrocannabinol in clinical oncology JAMA 245 1981 2047 2051
22. M.P. Carey, T.G. Burish, and D.E. Brenner Delta-9-tetrahydrocannabinol in cancer chemotherapy: Research problems and issues Ann Intern Med 99 1983 106 114
23. M. Levitt Cannabinoids as anti-emetics in cancer chemotherapy R. Mechoulam Cannabinoids as therapeutic agents 1986 CRC Press Boca Raton, Florida
24. R. Mechoulam, L.A. Parker, and R. Gallily Cannabidiol: An overview of some pharmacological aspects J Clin Pharmacol 42 2002 11S 19S
25. K. Meyer-Rosberg, A. Kvarnstrom, and E. Kinnman Peripheral neuropathic pain - a multidimensional burden for patients Eur J Pain 5 2001 379 389
26. I.D. Meng, B.H. Manning, W.J. Martin, and H.L. Fields An analgesia circuit activated by cannabinoids Nature 395 1998 381 383
27. L. Iversen, and V. Chapman Cannabinoids: A real prospect for pain relief? Curr Opin Pharmacol 2 2002 50 55
28. A.S. Rice, W.P. Farquhar-Smith, and I. Nagy Endocannabinoids and pain: Spinal and peripheral analgesia in inflammation and neuropathy Prostaglandins Leukot Essent Fatty Acids 66 2002 243 256
29. L. Iversen Cannabis and the brain Brain 126 2003 1252 1270
30. R. Noyes Jr., S.F. Brunk, D.A. Avery, and A.C. Canter The analgesic properties of delta-9-tetrahydrocannabinol and codeine Clin Pharmacol Ther 18 1975 84 89
31. M. Staquet, C. Gantt, and D. Machin Effect of a nitrogen analogue of tetrahydrocannabinol on cancer pain Clin Pharm Ther 23 1978 397 401
32. A.K. Jain, J.R. Ryan, F.G. McMahon, and G. Smith Evaluation of intramuscular levonantradol and placebo in acute postoperative pain J Clin Pharm 21 1981 320S 326S
33. A. Holdcroft, M. Smith, and A. Jacklin Pain relief with oral cannabinoids in familial Mediterranean fever Anaesthesia 52 1997 483 486
34. D.R. Taylor, and W. Hall Thoracic Society of Australia and New Zealand. Respiratory health effects of cannabis: Position statement of the Thoracic Society of Australia and New Zealand Intern Med J 33 2003 310 313
35. R. Randall Marijuana, medicine and the law, Vol. II 1999 Galen Press Washington, DC
36. D.I. Abrams, J.F. Hilton, and R.J. Leiser Short-term effects of cannabinoids in patients with HIV-1 infection Ann Intern Med 139 2003 258 266
37. G. Pryce, Z. Ahmed, and D.J. Hankey Cannabinoids inhibit neurodegeneration in models of multiple sclerosis Brain 126 2003 2191 2202
38. D.T. Wade, P. Robson, and H. House A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms Clin Rehabil 17 2003 21 29
39. I. Lastres-Becker, R. De Miguel, and J.J. Fernandez-Ruiz The endocannabinoid system and Huntington's disease Curr Drug Target CNS Neurol Disord 2 2003 335 347
40. R. Mechoulam, D. Panikashvili, and E. Shohami Cannabinoids and brain injury: Therapeutic implications Trends Mol Med 8 2002 58 61